CH605679A5 - - Google Patents
Info
- Publication number
- CH605679A5 CH605679A5 CH1619674A CH1619674A CH605679A5 CH 605679 A5 CH605679 A5 CH 605679A5 CH 1619674 A CH1619674 A CH 1619674A CH 1619674 A CH1619674 A CH 1619674A CH 605679 A5 CH605679 A5 CH 605679A5
- Authority
- CH
- Switzerland
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
- C07K1/061—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups
- C07K1/062—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents using protecting groups for alpha- or omega-carboxy functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/042—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers characterised by the nature of the carrier
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2360794A DE2360794C2 (de) | 1973-12-06 | 1973-12-06 | Verfahren zur Herstellung von Peptiden |
Publications (1)
Publication Number | Publication Date |
---|---|
CH605679A5 true CH605679A5 (xx) | 1978-10-13 |
Family
ID=5900062
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH1619674A CH605679A5 (xx) | 1973-12-06 | 1974-12-05 |
Country Status (12)
Country | Link |
---|---|
US (1) | US3960830A (xx) |
JP (1) | JPS5088003A (xx) |
BE (1) | BE823064A (xx) |
CH (1) | CH605679A5 (xx) |
DE (1) | DE2360794C2 (xx) |
DK (1) | DK633374A (xx) |
FR (1) | FR2253736B1 (xx) |
GB (1) | GB1464938A (xx) |
IE (1) | IE40281B1 (xx) |
LU (1) | LU71415A1 (xx) |
NL (1) | NL7415602A (xx) |
SE (1) | SE7415305L (xx) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3997516A (en) * | 1974-07-04 | 1976-12-14 | Takeda Chemical Industries, Ltd. | Method for protecting guanidino group and restoring the same |
DE2930542A1 (de) * | 1979-07-27 | 1981-02-12 | Hoechst Ag | Neue insulinderivate und verfahren zu ihrer herstellung |
US4585757A (en) * | 1984-07-27 | 1986-04-29 | Texas Tech University Health Sciences Center | Hypotensive active peptides |
US4766106A (en) * | 1985-06-26 | 1988-08-23 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
US5206344A (en) * | 1985-06-26 | 1993-04-27 | Cetus Oncology Corporation | Interleukin-2 muteins and polymer conjugation thereof |
US4847325A (en) * | 1988-01-20 | 1989-07-11 | Cetus Corporation | Conjugation of polymer to colony stimulating factor-1 |
US4908404A (en) * | 1988-08-22 | 1990-03-13 | Biopolymers, Inc. | Synthetic amino acid-and/or peptide-containing graft copolymers |
US5306500A (en) * | 1988-11-21 | 1994-04-26 | Collagen Corporation | Method of augmenting tissue with collagen-polymer conjugates |
US5162430A (en) * | 1988-11-21 | 1992-11-10 | Collagen Corporation | Collagen-polymer conjugates |
US5510418A (en) * | 1988-11-21 | 1996-04-23 | Collagen Corporation | Glycosaminoglycan-synthetic polymer conjugates |
US5565519A (en) * | 1988-11-21 | 1996-10-15 | Collagen Corporation | Clear, chemically modified collagen-synthetic polymer conjugates for ophthalmic applications |
US5166322A (en) * | 1989-04-21 | 1992-11-24 | Genetics Institute | Cysteine added variants of interleukin-3 and chemical modifications thereof |
JPH0520266U (ja) * | 1991-01-31 | 1993-03-12 | 松下電器産業株式会社 | 電気部品の接続装置 |
DE59205565D1 (de) * | 1991-10-07 | 1996-04-11 | Hoechst Ag | Carbonsäureester-Schutzgruppen, ein Verfahren zu ihrer Herstellung, ihre Kopplung an eine funktionelle Gruppe sowie ihre Verwendung |
US6833408B2 (en) * | 1995-12-18 | 2004-12-21 | Cohesion Technologies, Inc. | Methods for tissue repair using adhesive materials |
US7883693B2 (en) * | 1995-12-18 | 2011-02-08 | Angiodevice International Gmbh | Compositions and systems for forming crosslinked biomaterials and methods of preparation of use |
US6458889B1 (en) | 1995-12-18 | 2002-10-01 | Cohesion Technologies, Inc. | Compositions and systems for forming crosslinked biomaterials and associated methods of preparation and use |
WO1997022371A1 (en) * | 1995-12-18 | 1997-06-26 | Collagen Corporation | Crosslinked polymer compositions and methods for their use |
US20030220258A1 (en) * | 2001-12-21 | 2003-11-27 | Robbert Benner | Treatment of ischemic events |
DK1400551T3 (da) | 1998-08-28 | 2007-10-15 | Amylin Pharmaceuticals Inc | Polyamidkæder med præcis længde og deres konjugater med proteiner |
IL142282A0 (en) * | 1998-10-16 | 2002-03-10 | Biogen Inc | Compositions containing polymer conjugates of interferon-beta-1a |
US7358330B2 (en) * | 2001-03-29 | 2008-04-15 | Biotempt B.V. | Immunoregulatory compositions |
EP1300418A1 (en) * | 2001-10-04 | 2003-04-09 | Erasmus Universiteit Rotterdam | Gene regulation by oligopeptides |
US20080242837A1 (en) * | 2001-12-21 | 2008-10-02 | Khan Nisar A | Peptide compositions |
US8129330B2 (en) * | 2002-09-30 | 2012-03-06 | Mountain View Pharmaceuticals, Inc. | Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof |
ATE457716T1 (de) | 2002-12-30 | 2010-03-15 | Angiotech Int Ag | Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung |
US20040219214A1 (en) * | 2002-12-30 | 2004-11-04 | Angiotech International Ag | Tissue reactive compounds and compositions and uses thereof |
US7517529B2 (en) * | 2003-04-08 | 2009-04-14 | Biotempt B.V. | Treatment of type I diabetes |
US20090227505A1 (en) * | 2004-01-07 | 2009-09-10 | Biotempt B.V. | Methods and uses for protein breakdown products |
KR100974733B1 (ko) | 2004-04-28 | 2010-08-06 | 안지오디바이스 인터내셔널 게엠베하 | 가교된 생합성물질을 형성하기 위한 조성물 및 시스템, 및이와 관련된 제조 및 사용 방법 |
WO2006015365A1 (en) * | 2004-07-30 | 2006-02-09 | Mount Sinai School Of Medicine Of New York University | Npc1l1 and npc1l1 inhibitors and methods of use thereof |
US8303973B2 (en) | 2004-09-17 | 2012-11-06 | Angiotech Pharmaceuticals (Us), Inc. | Multifunctional compounds for forming crosslinked biomaterials and methods of preparation and use |
WO2007034812A1 (ja) | 2005-09-20 | 2007-03-29 | National University Corporation, Tokyo University Of Agriculture And Technology | 分離用担体、化合物の分離方法、及びこれを用いたペプチド合成方法 |
EP1864692A1 (en) * | 2006-06-07 | 2007-12-12 | Biotempt B.V. | Use of peptides for the control of radiation injury |
PT2120991E (pt) * | 2007-02-12 | 2014-05-02 | Biotempt Bv | Tratamento d a hemorragia traumática com oligopéptidos curtos |
US9051349B2 (en) | 2007-11-21 | 2015-06-09 | Alba Therapeutics Corporation | Larazotide acetate compositions |
EP2062909A1 (en) * | 2007-11-21 | 2009-05-27 | SOLVAY (Société Anonyme) | Peptide production and purification process |
US8486885B2 (en) | 2008-12-29 | 2013-07-16 | Trevena, Inc. | β-arrestin effectors and compositions and methods of use thereof |
US9518086B2 (en) * | 2014-02-07 | 2016-12-13 | Trevena, Inc. | Crystalline and amorphous forms of a β-arrestin effector |
AU2015264367A1 (en) | 2014-05-19 | 2016-12-15 | Trevena, Inc. | Synthesis of Beta-Arrestin Effectors |
EP3169406A4 (en) * | 2014-07-14 | 2018-01-10 | PEG Biosciences, Inc. | Polymeric enkephalin prodrugs |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE337223B (xx) * | 1967-05-23 | 1971-08-02 | Pharmacia Ab | |
US3502545A (en) * | 1968-09-27 | 1970-03-24 | Monsanto Co | Process for the separation of water-soluble polymeric materials from unbound protein or peptide using semiporous gel |
-
1973
- 1973-12-06 DE DE2360794A patent/DE2360794C2/de not_active Expired
-
1974
- 1974-11-29 NL NL7415602A patent/NL7415602A/xx unknown
- 1974-12-04 LU LU71415A patent/LU71415A1/xx unknown
- 1974-12-04 US US05/529,519 patent/US3960830A/en not_active Expired - Lifetime
- 1974-12-05 IE IE2512/74A patent/IE40281B1/en unknown
- 1974-12-05 CH CH1619674A patent/CH605679A5/xx not_active IP Right Cessation
- 1974-12-05 DK DK633374A patent/DK633374A/da unknown
- 1974-12-06 JP JP49141098A patent/JPS5088003A/ja active Pending
- 1974-12-06 SE SE7415305A patent/SE7415305L/xx not_active Application Discontinuation
- 1974-12-06 GB GB5298774A patent/GB1464938A/en not_active Expired
- 1974-12-06 BE BE151258A patent/BE823064A/xx unknown
- 1974-12-06 FR FR7440004A patent/FR2253736B1/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
GB1464938A (en) | 1977-02-16 |
NL7415602A (nl) | 1975-06-10 |
DE2360794A1 (de) | 1975-06-26 |
FR2253736B1 (xx) | 1978-09-15 |
JPS5088003A (xx) | 1975-07-15 |
BE823064A (fr) | 1975-06-06 |
US3960830A (en) | 1976-06-01 |
IE40281B1 (en) | 1979-04-25 |
IE40281L (en) | 1975-06-06 |
LU71415A1 (xx) | 1976-11-11 |
DK633374A (xx) | 1975-07-21 |
FR2253736A1 (xx) | 1975-07-04 |
SE7415305L (xx) | 1975-06-09 |
DE2360794C2 (de) | 1984-12-06 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |